AVANOS MEDICAL, INC. (NYSE:AVNS) Shares Sold by Teacher Retirement System of Texas

Teacher Retirement System of Texas lowered its stake in AVANOS MEDICAL, INC. (NYSE:AVNS - Free Report) by 62.6% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 23,484 shares of the company's stock after selling 39,387 shares during the quarter. Teacher Retirement System of Texas owned approximately 0.05% of AVANOS MEDICAL worth $337,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of AVNS. T. Rowe Price Investment Management Inc. boosted its stake in shares of AVANOS MEDICAL by 27.2% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 3,011,312 shares of the company's stock worth $47,941,000 after purchasing an additional 644,267 shares during the last quarter. Brown Advisory Inc. lifted its stake in shares of AVANOS MEDICAL by 12.0% during the fourth quarter. Brown Advisory Inc. now owns 1,905,094 shares of the company's stock valued at $30,329,000 after buying an additional 204,218 shares during the period. D. E. Shaw & Co. Inc. boosted its position in AVANOS MEDICAL by 43.1% during the fourth quarter. D. E. Shaw & Co. Inc. now owns 494,627 shares of the company's stock worth $7,874,000 after acquiring an additional 148,902 shares during the last quarter. JPMorgan Chase & Co. boosted its position in AVANOS MEDICAL by 189.8% during the fourth quarter. JPMorgan Chase & Co. now owns 201,634 shares of the company's stock worth $3,210,000 after acquiring an additional 132,063 shares during the last quarter. Finally, Bridgeway Capital Management LLC grew its stake in AVANOS MEDICAL by 87.6% in the 4th quarter. Bridgeway Capital Management LLC now owns 273,251 shares of the company's stock worth $4,350,000 after acquiring an additional 127,591 shares during the period. Hedge funds and other institutional investors own 95.17% of the company's stock.

AVANOS MEDICAL Trading Down 3.4%

AVNS traded down $0.39 during midday trading on Friday, hitting $11.25. The company's stock had a trading volume of 450,766 shares, compared to its average volume of 392,907. AVANOS MEDICAL, INC. has a 52-week low of $11.21 and a 52-week high of $25.36. The firm has a 50-day moving average price of $12.32 and a two-hundred day moving average price of $13.85. The company has a current ratio of 2.57, a quick ratio of 1.56 and a debt-to-equity ratio of 0.12. The firm has a market cap of $520.20 million, a P/E ratio of 8.07 and a beta of 1.12.

AVANOS MEDICAL (NYSE:AVNS - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 EPS for the quarter, topping analysts' consensus estimates of $0.19 by $0.07. The business had revenue of $167.50 million during the quarter, compared to the consensus estimate of $161.75 million. AVANOS MEDICAL had a positive return on equity of 6.26% and a negative net margin of 55.80%. The business's revenue for the quarter was up .8% on a year-over-year basis. During the same period in the prior year, the firm posted $0.22 EPS. On average, research analysts anticipate that AVANOS MEDICAL, INC. will post 1.32 earnings per share for the current year.

AVANOS MEDICAL Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.